Gland Pharma also established that its version is bioequivalent and therapeutically equivalent to the reference listed drug.

Gland Pharma receives USFDA approval for Angiotensin II Acetate Injection, a generic drug with exclusive rights and high ...

The pharmaceutical company has received approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Angiotensin II Acetate injection 2.5 mg ...

Gland Pharma stock surged 2 per cent in the Wednesday trading session after the pharmaceutical firm obtained approval from ...

Hyderabad: Gland Pharma Limited, a generic injectable & ophthalmicfocused pharmaceutical company, has announced that the ...

Gland Pharma's generic version of Giapreza injection approved by FDA for increasing blood pressure in adults with shock.

In a stock exchange filing, the company said it has received approval from the US drug regulator for Angiotensin II Acetate ...

The city based Gland Pharma on Wednesday announced receiving the approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application for Angiotensin II ...

All level pairs (n=18 732) of 4 widely used high‐sensitivity cardiac troponin T/I (hs‐cTnT/I) assays using (1) the regulatory‐approved uniform and sex‐specific clinical ULN and (2) mathematically ...

Gland Pharma shares rose after it secured United States Food and Drug Administration (USFDA) approval for its Abbreviated New ...